PMID: 11900987Mar 20, 2002Paper

Endogenous type I interferons as a defense against tumors

Cytokine & Growth Factor Reviews
I Gresser, F Belardelli

Abstract

We have reviewed the experimental results which indicate that endogenous type I interferon (IFN) present either constitutively or possibly induced by the tumor plays an important role in limiting the development of transplantable tumors in mice. Thus, treatment with potent polyclonal neutralizing antibodies to IFN alpha/beta markedly enhanced the subcutaneous growth, invasiveness and metastases of xenogeneic tumor cells (uninfected or infected with RNA or DNA viruses) in athymic nude mice; enhanced the intraperitoneal transplantability of six different syngeneic murine tumors in three strains of immunocompetent mice; and completely abrogated the resistance of allogeneic C57Bl/6 (H-2(b)) or C3H (H-2(k)) mice to the multiplication of Friend erythroleukemia cells (H-2(d)) in the liver and spleen resulting in the death of most mice. The mechanisms by which mice respond to the injection of relatively few tumor cells appear to be multiple, to depend on the site of tumor growth, to occur early and prior to an immunologic response. Endogenous type I IFN appears to constitute an essential component of these defense mechanisms enabling the host to restrict tumor growth.

References

Oct 27, 1978·Biochimica Et Biophysica Acta·I Gresser, M G Tovey
Oct 1, 1991·British Journal of Haematology·I Gresser
Feb 15, 1990·International Journal of Cancer. Journal International Du Cancer·I GresserF Belardelli
Apr 5, 1989·Journal of the National Cancer Institute·H F Dvorak, I Gresser
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M G ToveyM Gigou
Jan 1, 1988·Annual Review of Medicine·I Penn
Aug 20, 1987·The New England Journal of Medicine·F H Bach, D H Sachs
Oct 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·P LindahlI Gresser
May 1, 1969·Proceedings of the National Academy of Sciences of the United States of America·I GresserM T Thomas
Feb 1, 1981·Biological Reviews of the Cambridge Philosophical Society·V Bocci
Jun 1, 1982·The Journal of Experimental Medicine·D Fradelizi, I Gresser
Sep 24, 1982·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·I Gresser
Dec 15, 1982·International Journal of Cancer. Journal International Du Cancer·F BelardelliM T Maunoury
Dec 15, 1982·International Journal of Cancer. Journal International Du Cancer·F BelardelliM T Maunoury
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·F BelardelliI Gresser
Dec 1, 1983·The Journal of Experimental Medicine·I GresserM G Tovey
Mar 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·F Belardelli
May 15, 1994·International Journal of Cancer. Journal International Du Cancer·I GresserF Belardelli
Dec 26, 1996·The New England Journal of Medicine·M J NewportM Levin
Dec 26, 1996·The New England Journal of Medicine·E JouanguyJ L Casanova
Nov 14, 1964·Nature·K E HELLSTROEMG HAUGHTON
Jan 1, 1985·Immunology Today·V Bocci

❮ Previous
Next ❯

Citations

Apr 28, 2004·Cytokine & Growth Factor Reviews·Dhananjaya V Kalvakolanu
Dec 18, 2002·Cytokine & Growth Factor Reviews·Andrei Thomas-Tikhonenko, Christopher A Hunter
Mar 26, 2003·Cytokine & Growth Factor Reviews·Timothy A Stewart
Jun 23, 2005·Nature Immunology·Mark J Smyth
Jun 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Padmaja GadeDhananjaya V Kalvakolanu
Jan 7, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Stefano M SantiniFilippo Belardelli
Dec 2, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Sanjit K RoyDhananjaya V Kalvakolanu
Dec 27, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Dhananjaya V Kalvakolanu, Sanjit K Roy
Jan 11, 2008·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kazuko UnoTsunataro Kishida
Jun 19, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Ion Gresser
Feb 6, 2008·Molecular and Cellular Biology·Padmaja GadeDhananjaya V Kalvakolanu
Mar 20, 2010·The Journal of Clinical Investigation·Jadwiga JablonskaSiegfried Weiss
Dec 21, 2013·Cancer Immunology, Immunotherapy : CII·Joanne Y H LimEdith M Lord
Aug 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Luiz F Leomil CoelhoGilles Uzé
Sep 13, 2007·Critical Reviews in Biotechnology·Mehrdad HamidiMahshid Foroozesh
Mar 20, 2010·Autoimmunity·Silvano SozzaniAngela Tincani
Nov 11, 2015·Drug Discovery Today·Ahmed LasfarKarine A Cohen-Solal
Aug 27, 2015·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Run TongShujun Cheng
Jun 21, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Alfons Billiau
May 22, 2007·International Journal of Pharmaceutics·M HamidiS Mohammadi-Samani
Nov 18, 2004·Immunological Reviews·Mark J SmythYoshihiro Hayakawa
Jun 20, 2014·Immunological Reviews·Hyeseon Cho, Brian L Kelsall
Jan 26, 2013·The International Journal of Biochemistry & Cell Biology·Aimei LiFengmin Zhang
Apr 13, 2010·Cytokine·Dhan V KalvakolanuSudhakar Kalakonda
Feb 3, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jiabing ChenEleanor N Fish
Aug 24, 2013·Cell Cycle·Laura Marcos-VillarCarmen Rivas
Aug 17, 2004·Immunity·Gavin P DunnRobert D Schreiber
Apr 27, 2016·International Journal of Cancer. Journal International Du Cancer·Lisa AndzinskiStefan Lienenklaus
Sep 24, 2016·Cytokine & Growth Factor Reviews·Shreeram C Nallar, Dhan V Kalvakolanu
Aug 28, 2003·Nature Immunology·Jan Vilcek
Jun 7, 2013·The Cochrane Database of Systematic Reviews·Aramide O LawalLiesl Grobler
Dec 18, 2012·Molecular Medicine Reports·Aimei LiFengmin Zhang
Aug 22, 2003·The Journal of Biological Chemistry·Vincent van Pesch, Thomas Michiels
Apr 22, 2017·Frontiers in Immunology·Kevin P KotredesAna M Gamero
Jan 27, 2019·Nature Reviews. Drug Discovery·Ernest C Borden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved